Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb
Table S1. Comparison of the citizens with and without liver ultrasonography among those with altered...
Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...
Table S2. Meta-regression analysis to assess the influence of continuous variables on the effect siz...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...
Figure S1. The portion of chronic LFTs abnormalities and NAFLD patients according to Non-HDL/ HDL le...
Table S1. Characteristics of the primary-care databases included in the study. Figure S1. Identifica...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Table S3. Natural logarithm transformed data for NAFLD stages analysis. (DOCX 12 kb
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
Table S1. Natural logarithm transformed data in our four groups of patients and controls. (DOCX 13 k...
Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...
Figure S1. PR3 concentrations measured in plasma samples versus serum samples. (PPTX 65 kb
Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....
Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...
Table S1. Comparison of the citizens with and without liver ultrasonography among those with altered...
Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...
Table S2. Meta-regression analysis to assess the influence of continuous variables on the effect siz...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...
Figure S1. The portion of chronic LFTs abnormalities and NAFLD patients according to Non-HDL/ HDL le...
Table S1. Characteristics of the primary-care databases included in the study. Figure S1. Identifica...
SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documen...
Table S3. Natural logarithm transformed data for NAFLD stages analysis. (DOCX 12 kb
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
Table S1. Natural logarithm transformed data in our four groups of patients and controls. (DOCX 13 k...
Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...
Figure S1. PR3 concentrations measured in plasma samples versus serum samples. (PPTX 65 kb
Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....
Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...
Table S1. Comparison of the citizens with and without liver ultrasonography among those with altered...
Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...
Table S2. Meta-regression analysis to assess the influence of continuous variables on the effect siz...